The Claim

In patients with Hashimoto thyroiditis, thyroid tissue exhibits significantly higher expression of FOXP3+ regulatory T cells (100% of samples) compared to nonautoimmune controls (8.3%), with no difference in CD25+ expression, indicating the presence of a distinct population of chronically activated regulatory T cells within the inflamed gland.

Source: Interplay between expression of PD-L1 on thyrocytes and intrathyroidal lymphocytes and FOXP3 as a marker of regulatory T lymphocytes in Hashimoto thyroiditis.

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
42score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

In people with Hashimoto thyroiditis, thyroid tissue contains a much higher proportion of FOXP3+ regulatory T cells than thyroid tissue from people without autoimmune disease, while CD25+ expression levels are similar, suggesting a unique subset of regulatory T cells is present in the inflamed thyroid.

See the scientific wording

In patients with Hashimoto thyroiditis, thyroid tissue shows significantly higher expression of FOXP3+ regulatory T cells (100% of samples) compared to nonautoimmune controls (8.3%), despite no difference in CD25+ expression, suggesting the presence of a distinct population of chronically activated regulatory T cells within the inflamed gland.

Why this might work

In the inflamed thyroid, persistent exposure to self-antigens and inflammatory signals causes regulatory T cells to become permanently activated and change their surface markers — they keep producing FOXP3 but stop making CD25, while increasing PD-1. These specialized cells suppress other immune cells through chemical signals and direct contact, preventing rapid destruction of thyroid tissue but failing to fully stop the autoimmune process.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: Interplay between expression of PD-L1 on thyrocytes and intrathyroidal lymphocytes and FOXP3 as a marker of regulatory T lymphocytes in Hashimoto thyroiditis.

    In people with Hashimoto’s, the thyroid has way more of a special type of immune cell (FOXP3+) that helps calm inflammation, but another marker (CD25) isn’t higher—meaning these calming cells are different and maybe stuck in the thyroid trying to fix the damage.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.